🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
78.47
+1.90 (2.47%)
Nov 18, 2026, 12:51 PM EST - Market open

Disc Medicine Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Disc Medicine stock has a consensus rating of "Strong Buy" and an average price target of $127.69. The average 1-year stock price forecast is 62.73% higher than the current stock price, while the lowest is $104 (+32.54%) and the highest is $170 (+116.66%).

Price Target: $127.69 (+62.73%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$104$127.69$127$170
Change+32.54%+62.73%+61.86%+116.66%

Analyst Ratings

The average analyst rating for Disc Medicine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy121212121212
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total131313131313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$92 → $104
BuyReiterates$92 → $104+32.54%Nov 18, 2026
BMO Capital
BMO Capital
Buy
Maintains
$120
BuyMaintains$120+52.93%Nov 10, 2026
Guggenheim
Guggenheim
Buy
Initiates
$132
BuyInitiates$132+68.23%Nov 9, 2026
Truist Financial
Truist Financial
Buy
Maintains
$115
BuyMaintains$115+46.56%Nov 6, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$120 → $127
BuyReiterates$120 → $127+61.86%Nov 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
43.54M
EPS This Year
-6.11
from -6.01
EPS Next Year
-6.18
from -6.11
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------
Operating Income
-30.93M-47.48M-91.13M-129.72M-235.17M-273.15M
Net Income
-35.97M-46.83M-76.43M-109.36M-212.18M-254.79M
EPS
-----6.01-6.11
Free Cash Flow
-----181.33M-233.35M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-5.11
Avg-6.11
Low-6.44

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-